Loading...
Loading...
Below are the top biotechnology stocks on the NYSE and the NASDAQ in terms of earnings per share.
The trailing-twelve-month earnings per share at Portola Pharmaceuticals
PTLA is $9.52. Portola Pharma's revenue for the same period is $9.80 million.
The trailing-twelve-month earnings per share at Biogen Idec
BIIB is $8.04. Biogen Idec's PEG ratio is 2.04.
The trailing-twelve-month earnings per share at Intrexon
XON is $6.21. Intrexon's revenue for the same period is $27.70 million.
The trailing-twelve-month earnings per share at Amgen
AMGN is $6.16. Amgen's ROE for the same period is 21.70%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in